4 Healthcare Stocks Stories Aimed At Investment Wellness

Eli Lilly and Company (NYSE:LLY): Closing price $49.22

Lilly has prevailed in a United Kingdom patent lawsuit against a Johnson & Johnson unit regarding a potential treatment for Alzheimer’s disease. Judge Richard Arnold said in a ruling in London on Tuesday that a patent held by J&J’s Janssen Alzheimer Immunotherapy Research & Development division is not valid. Both firms are working on treatments that target the accumulation of plaque in patients’ brains, which is linked to the condition. Companies developing treatments for Alzheimer’s are vying to be first  to enter what could be a $20-billion market, according to a report released in 2012 by Deutsche Bank analysts. The United States spokesman for Janssen, Greg Panico, wrote in an e-mail that the unit is “disappointed by the outcome of this case, and we are considering our options.”

Are these stocks a buy or sell? Let us help you decide. LLY